On July 11, 2022, Halo Collective Inc. closed the transaction. The company has received $6,000,000 in its Series C round of funding led by new investor, Agilent Technologies, Inc. and included participation from existing investors, Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and members of the Board of Directors and senior management. The company has received $5,999,994 pursuant to exemption provided under Regulation D from 11 investors.